Description
Mechanism of Action
CJC-1295 (No DAC) functions as a growth hormone-releasing hormone (GHRH) analogue, stimulating the pituitary gland to increase GH secretion. Ipamorelin complements this action as a selective ghrelin receptor agonist, promoting GH release without significantly impacting cortisol or prolactin levels. Together, they create a more natural and controlled GH pulse.
Key Advantages
- Supports natural growth hormone release
- Promotes recovery and tissue repair pathways
- May assist in lean body composition research
- Synergistic dual-peptide formulation
- Minimal impact on cortisol and prolactin
Application
Ideal for research focused on growth hormone optimization, recovery enhancement, performance support, and body recomposition protocols.
Composition
- CJC-1295 (No DAC) – 5mg
- Ipamorelin – 5mg
Each batch is produced under strict quality control standards to ensure purity, stability, and consistency.
Quality Commitment
Preme Research maintains rigorous standards in sourcing and formulation. Our peptide blends are handled with precision to ensure integrity and reliability for research applications.
Storage
Store in a cool, dry environment away from direct sunlight. Proper storage conditions are essential to maintain compound stability.
Important Notice
This product is intended for research purposes only. Not approved for human consumption.
Disclaimer
All information provided is for educational and research purposes only. Results may vary depending on methodology and application.
Preme Research Standard
Engineered for precision. Trusted for quality. Built for research excellence.
